Invivyd

Invivyd

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.52-$3.06
Market Cap
$269.2M
Shares Short
29M

Financials

See more
Revenue (12 Mos)
$58.3M
Revenue Growth (YoY)
21.2%
Gross Profit (12 Mos)
$53.8M
Diluted EPS
-$0.31

News

See more

Yahoo Finance • 2 months ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Yahoo Finance • 3 months ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 4 months ago

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration

Yahoo Finance • 5 months ago

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

About

CEO
Mr. Marc William Elia
CFO
Mr. William E. Duke Jr., M.B.A.
Address
209 Church Street, New Haven, CT, United States, 06510
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
122